Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C. Urban, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 43
Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine
Amber Hsiao, John Hansen, Julius Timbol, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e221111-e221111
Open Access | Times Cited: 37
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
Susanne Simon, Oana Joean, Tobias Welte, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 230034-230034
Open Access | Times Cited: 22
From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
Robert Root‐Bernstein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3001-3001
Open Access | Times Cited: 20
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps
Anabelle Wong, Laura Andrea Barrero Guevara, Elizabeth Goult, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011167-e1011167
Open Access | Times Cited: 19
Streptococcus pneumoniae carriage studies in adults: Importance, challenges, and key issues to consider when using quantitative PCR-based approaches
Willem R. Miellet, Antonio Almeida Silva, Krzysztof Trzciński, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 17
Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?
Eileen M. Dunne, Catia Cillóniz, Claire von Mollendorf, et al.
Archivos de Bronconeumología (2023) Vol. 59, Iss. 3, pp. 157-164
Open Access | Times Cited: 15
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 15
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age
Tosin Omole, Enrique Pelayo, Aaron S. Weinberg, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 192-192
Open Access
Evaluating the association between routine pneumococcal vaccination and COVID-19 severity among older adults in the United States: A case control study
Ottavia Prunas, Andrew Tiu, Kayoko Shioda, et al.
Vaccine X (2025), pp. 100622-100622
Open Access
Atemwegsinfektionen im Alter: RSV, Covid, Influenza, Pneumokokken & Co.
Anja Kwetkat, Anne–Sophie Endres, Hans Jürgen Heppner, et al.
CME (2025) Vol. 22, Iss. 3, pp. 51-66
Closed Access
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults
Joseph A. Lewnard, Katia Bruxvoort, Heidi Fischer, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 5, pp. 832-841
Open Access | Times Cited: 35
Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
Anna M Parker, Nicole Jackson, Shevya Awasthi, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1209-1217
Open Access | Times Cited: 19
Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
Joseph A. Lewnard, Katia Bruxvoort, Vennis Hong, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 4, pp. 498-511
Open Access | Times Cited: 18
RSV and Rhinovirus asymptomatic upper airway infection increases pneumococcal carriage acquisition rates and density in adults whereas nasal inflammation is associated with bacterial shedding
Elena Mitsi, Elissavet Nikolaou, André Fernando Nascimento Gonçalves, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding
Elena Mitsi, Elissavet Nikolaou, André Fernando Nascimento Gonçalves, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 9, pp. 1608-1620.e4
Closed Access | Times Cited: 3
The impact of COVID-19 on routine vaccinations in Taiwan and an unexpected surge of pneumococcal vaccination
Nan‐Chang Chiu, Kai-Hsun Lo, Chung-Chu Chen, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 17
Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study
Amanda Eiden, Anthony DiFranzo, Alexandra Bhatti, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 481-494
Open Access | Times Cited: 9
Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection
Eileen M. Dunne, Marta C. Nunes, Mary Slack, et al.
Pneumonia (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
DrugWAS: Drug‐wide Association Studies for COVID‐19 Drug Repurposing
Cosmin A. Bejan, Katherine N. Cahill, Patrick Staso, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 6, pp. 1537-1546
Open Access | Times Cited: 21
Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths
Robert Root‐Bernstein
Vaccines (2021) Vol. 9, Iss. 5, pp. 474-474
Open Access | Times Cited: 20
Modeling the crossover behavior of the bacterial infection with the COVID-19 epidemics
Zhenhua Yu, Ayesha Sohail, Robia Arif, et al.
Results in Physics (2022) Vol. 39, pp. 105774-105774
Open Access | Times Cited: 14
Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein
Maritza J. Romero, Yue Qian, Bhupesh Singla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature Review
Ingrid T. Sepúlveda-Pachón, Eileen M. Dunne, Germaine Hanquet, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e657-e667
Open Access | Times Cited: 2
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination
Vincenzo Puro, Concetta Castilletti, Chiara Agrati, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 615-615
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top